Literature DB >> 9641180

Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs.

M Ozkahya1, E Ok, M Cirit, S Aydin, F Akçiçek, A Başçi, E J Dorhout Mees.   

Abstract

BACKGROUND: Left ventricular hypertrophy (LVH) is very frequent in haemodialysis patients. Only few investigations have reported its regression, and only by the use of antihypertensive drugs. Because volume load is at least as important as pressure load, we investigated whether persistent strict volume control by ultrafiltration alone may be effective in improving LVH
METHODS: Using blood pressure (BP) and cardiac dimensions as a guide, we treated all hypertensive patients in our dialysis unit during the 3 times weekly dialysis sessions for 4 h per session with as much ultrafiltration as they could stand. If they gained too much weight an extra isolated ultrafiltration (UF) session was applied. Special attention was given to dietary salt restriction. The study group of all 15 patients in whom echocardiographic assessment had been made at least 1.5 years previously was selected retrospectively, and we acknowledge that important confounding factors might not have been controlled for. Cardiothoracic index (CTI) was estimated on the chest X-ray. Diameters of left atrium (LA), left ventricle systolic (LVS) and diastolic (LVD), interventricular septum (IVS), posterior wall (PW), and left ventricular mass index (LVMI) were estimated by standard echocardiographic methods.
RESULTS: Mean arterial pressure of the study group had been lowered by UF before the first echocardiogram from predialysis 136+/-11 to 101+/-14 and from postdialysis 119+/-8 to 92+/-12 mmHg. During a mean follow-up period of 37+/-11 months LVMI decreased from 175+/-60 to 105+/-11 g/m2. CTI decreased further from 48+/-3 to 43+/-4%, while significant decreases of LA (22.5+/-3 to 19.9+/-4 mm/m2), LVS (18.7+/-4 to 15.9+/-3 mm/m2) and LVD (28.3+/-4 to 24.0+/-3 mm/m2) were seen in all patients. There also was a further decrease in both pre- and postdialysis BP to 116+/-12/73+/-7 and 105+/-7/65+/-3 mmHg respectively.
CONCLUSION: The results of this uncontrolled retrospective study suggest that good long-term BP control and a decrease of LVM can be achieved by continuous efforts to control hypervolaemia. The decrease in volume may be even more important than pressure reduction to achieve this goal.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9641180     DOI: 10.1093/ndt/13.6.1489

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  31 in total

1.  Non-Linear Heart Rate Variability Indices in the Frequent Hemodialysis Network Trials of Chronic Hemodialysis Patients.

Authors:  Manuela Ferrario; Jochen G Raimann; Brett Larive; Andreas Pierratos; Stephan Thijssen; Sanjay Rajagopalan; Tom Greene; Sergio Cerutti; Gerald Beck; Christopher Chan; Peter Kotanko
Journal:  Blood Purif       Date:  2015-07-04       Impact factor: 2.614

Review 2.  Kt/V (and especially its modifications) remains a useful measure of hemodialysis dose.

Authors:  John T Daugirdas
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

3.  Probing dry-weight improves left ventricular mass index.

Authors:  Rajiv Agarwal; J Michael Bouldin; Robert P Light; Ashok Garg
Journal:  Am J Nephrol       Date:  2010-12-13       Impact factor: 3.754

4.  Changes in pulse pressure during hemodialysis treatment and survival in maintenance dialysis patients.

Authors:  Paungpaga Lertdumrongluk; Elani Streja; Connie M Rhee; John J Sim; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-01       Impact factor: 8.237

5.  Hypervolemia rather than arterial calcification and extracoronary atherosclerosis is the main determinant of pulse pressure in hemodialysis patients.

Authors:  Halil Yazici; Huseyin Oflaz; Hamdi Pusuroglu; Savas Tepe; Cengiz Dogan; Ali Basci; Vakur Akkaya; Alaattin Yildiz
Journal:  Int Urol Nephrol       Date:  2011-07-05       Impact factor: 2.370

6.  Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.

Authors:  Christopher T Chan; Tom Greene; Glenn M Chertow; Alan S Kliger; John B Stokes; Gerald J Beck; John T Daugirdas; Peter Kotanko; Brett Larive; Nathan W Levin; Ravindra L Mehta; Michael Rocco; Javier Sanz; Brigitte M Schiller; Phillip C Yang; Sanjay Rajagopalan
Journal:  Circ Cardiovasc Imaging       Date:  2012-02-23       Impact factor: 7.792

7.  Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD-III): a randomized controlled trial for clinical outcomes.

Authors:  Chen Huan-Sheng; Chang Yeong-Chang; Hsieh Ming-Hsing; Tseng Fan-Lieh; Lin Chu-Cheng; Wu Tsai-Kun; Chen Hung-Ping; Hung Sze-Hung; Chiu Hsien-Chang; Lee Chia-Chen; Hou Chun-Cheng; Cheng Chun-Ting; Liou Hung-Hsiang; Lin Chun-Ju; Lim Paik-Seong
Journal:  Int Urol Nephrol       Date:  2016-09-12       Impact factor: 2.370

8.  Bioimpedance spectroscopy method to determine hypervolemia in maintenance hemodialysis patients.

Authors:  O Merhametsiz; E G Oguz; O Yayar; B Bektan; B Canbakan; D Ayli
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

9.  Low dietary sodium intake increases the death risk in peritoneal dialysis.

Authors:  Jie Dong; Yanjun Li; Zhikai Yang; Jianfeng Luo
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 8.237

Review 10.  Management of hypertension in hemodialysis patients.

Authors:  C Venkata S Ram; Andrew Z Fenves
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.